Top 5 Gainers and Losers: GSHR.V, KCC.V, LUX.CN

In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets.

Here is a summary of the intraday action of assets:

Top 5 Gainers

Lomiko Metals (LMR.V)

Market Cap ~ $26 million

Lomiko Metals Inc. engages in the acquisition, exploration, and development of resource properties in Canada. It explores for graphite and lithium deposits. The company’s flagship project is its 100% owned La Loutre graphite property located in Laurentian region of Quebec.

The stock is up 8% on no news.

The breakout rally continues with strong price action today as well. The next resistance remains the $0.08-$0.10 zone, a zone the stock could very well test today if not this week.

Goldshore Resources (GSHR.V)

Market Cap ~ $68 million

Goldshore Resources Inc., a junior gold development company, engages in the acquisition and evaluation of precious metal mineral properties in Canada. It owns the Moss Lake gold project and the Hillcrest Project; and an option to earn-in to the Vanguard Project, located in Ontario, Canada.

The stock is up 15% on news that 19,096,083 common shares of the Company have been purchased in a private transaction involving SAF Group.

This is the type of chart structure I look for. We had a double bottom pattern confirmed with the breakout and retest at $0.16. Now, the stock is in the process of forming its second higher low in this uptrend. As long as the stock remains above $0.21, the uptrend remains intact.

Kincora Copper (KCC.V)

Market Cap ~ $14 million

Kincora Copper Limited engages in acquisition, exploration, and evaluation of mineral properties in Mongolia and Australia. It primarily explores for copper, gold, lead, zinc, and silver deposits.

The stock is up 57% on news the Company has signed a definitive multiple-phase Earn-in and Joint Venture Agreement with a wholly owned subsidiary of AngloGold Ashanti plc for the Northern Junee-Narromine Belt Project.

The stock has been bottoming in recent months, and it looks like this news can finally kick off a trend reversal. A close above $0.05 would be strong, but even better would be a candle close above the $0.06 level as it would take out the previous wick highs. Looks like a double bottom pattern reversal could be triggering.

Bravo Mining (BRVO.V)

Market Cap ~ $334 million

Bravo Mining Corp. engages in the acquisition, exploration, operation, and development of mineral properties. It primarily focuses on the Luanga project, a palladium, platinum, rhodium, gold, and nickel deposits project, that consists of 7,810 hectares mining exploration license located in the Carajás Mineral Province, Pará State, Brazil.

The stock is up 41% on news it has intersected high-grade IOCG-style massive sulphide copper-gold mineralization in drill testing of Luanga EM targets.

The market loves the news, and today’s price action is very likely to confirm our first higher low here with a close above $2.40. Watch for a resistance test at $3.20. A close above this level would be huge for the stock.

Newlox Gold Ventures (LUX.CN)

Market Cap ~ $19 million

Newlox Gold Ventures Corp. operates as an environmental remediation and mineral recovery company. The company undertakes tailings remediation and gold recovery projects in Costa Rica.

The stock is up 20% on news production has started at Plant 2 of the Boston Clean Project.

Breakout traders should have this stock on their radar. After a pop last year, the stock has just been drifting in a flag pattern with well defined trendlines providing support and resistance. The stock could confirm a breakout with today’s close. Still a lot of trading left in the day!

Top 5 Losers

MedBright AI Investments (MBAI.CN)

Market Cap ~ $12 million

MedBright AI Investments Inc. invests in healthcare technology companies.

The stock is down 14% on no news.

A big breakdown could be confirmed by the end of the trading day today. Sellers are looking to take out support here at $0.13. A close below would see a move down to the $0.08 zone.

Avanti Gold (AGC.CN)

Market Cap ~ $7.5 million

Avanti Gold Corp. operates as a mineral exploration company. It engages in the exploration of gold properties. The company holds agreement to acquire a 100% interest in the Black Dog Lake gold property, which comprises various contiguous mineral claims covering 1,319.4 hectares located in the James Bay region of Quebec; holds 100% interest in the Wing Shear property that comprises various claim units covering 7,000 hectares situated northeast of Gander, Newfoundland and Labrador; and holds interest in Misisi Gold Project located in the Fizi territory of South Kivu province in the Democratic Republic of the Congo.

The stock is down 13% on no news.

A reversal could be in danger with today’s price action. Watch to see if bulls can keep the stock above $0.155. A close below $0.12 would nullify bullish potential.

Premier Health of America (PHA.V)

Market Cap ~ $16 million

Premier Health of America Inc., together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes. It also offers health consulting, nursing, and healthcare services in remote communities, as well as provides nursing and assistance services in remote regions; and Code Bleu, an agency to employ staff nurses. The company provides its services through PSweb, a CRM platform.

The stock is down 12% on no news.

The stock is testing a key support here at $0.28. Will bulls step in? If not, the sell off will continue down to the $0.22 zone.

FSD Pharma Inc (HUGE.CN)

Market Cap ~ $19 million

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.

The stock is down 10% on news it has submitted a clinical trial protocol to study the safety and efficacy of Unbuzzd in acute alcohol intoxication.

Yes there is a downtrend, but the stock is beginning to range here. Watch for a close above $0.55 to trigger a breakout reversal. So far, bears are jumping in at resistance.